Number two, we are trying to stabilize long term demand through long term contracts from the government, which is the biggest buyer of pharmaceuticals. And three, a la the broader issue of regulatory reform, We are going to make it much easier for advanced manufacturing, continuous manufacturing to occur here. and make us competitive. So that's kind of the thrust of the eo. Now here's the backstory for the American people. You have a process which goes in three stages. (01:17–01:25)
CLAIM
Asserts plans to facilitate advanced manufacturing in the U.S.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
